Pharmaceutical Care Services

 

The King Faisal Specialist Hospital & Research Center (KFSH&RC) in Riyadh, Saudi Arabia, is a 1086-bed tertiary care facility that provides the highest level of specialized healthcare in an integrated educational and research setting. Its center of excellence in cardiology, oncology, and solid organ transplant are well recognized throughout the Middle East as well as the rest of the world. The standard of care that KFSH&RC provides are reflected through some of its breakthrough achievements. For example, JCIA standards, MAGNET recognition, HIMSS EMRAM Ambulatory Stage 7, etc. 

The Pharmaceutical Care division of King Faisal Specialist Hospital and Research Center (KFSHR&RC) is well reputed for its excellence in patient care services, state-of-the-art pharmacy automation systems, and superior quality of education and training throughout the Middle East. The current organizational structure of the Pharmaceutical Care Division is geared towards integrated clinical services model. Specifically, to reduce the perceived and real barrier between what is considered clinical work and pharmacy operation, and to ensure the safe and effective use of medications.

The Pharmaceutical Care Division is composed of three departments: Ambulatory Care Pharmacy, Medical/Critical Care Pharmacy, and Medication Safety/Clinical Pharmacy Support Services. The Division provides comprehensive, 24-hour computerized services to both inpatients and outpatients settings focusing patient-center care and integrated model of pharmaceutical care. Its exceptional multinational staff, cutting edge technology/automation, state-of-the-art informatics resources, and facilities have undoubtedly made it one of the leading hospital pharmacies in the Middle East. It employs approximately 300 personnel with 28 clinical pharmacy consultants, clinical pharmacy specialists and clinical pharmacists in different clinical practice areas such as ambulatory care, anticoagulation, cardiology, drug information, internal medicine, infectious diseases, nephrology, oncology, pediatrics, adult and pediatric critical care, parenteral nutrition, solid organ transplantation, and surgery.

 Pharmacy Mission

To provide comprehensive pharmaceutical care that will yield safe and cost-effective drug therapy in an integrated education, training and research settings.

Pharmacy Values:

  • Patient Focus: We put the needs for our patients first.
  • Integrity: We adhere to high ethical principles to be truthful, transparent, equitable and trustworthy.
  • Quality: We strive for excellence and high quality through creativity and innovation.
  • Compassion: We treat patients, families, and team members with dignity and kindness.
  • Teamwork: We work well together to ensure that knowledge and wisdom are shared for the benefit of all.

Goals and Objectives:

  • To maximize rational, cost-effective drug use by increasing pharmacists presence in patient care areas and by contributing to the medication use evaluation process, formulary control and medication therapy monitoring.
  • To exceed standards for medication use established by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO/JCIA).
  • To exceed standards of pharmacy practice established by the American Society of Health-System Pharmacists (ASHP), American College of Clinical Pharmacy (ACCP) and the Saudi Ministry of Health (MOH).
  • To create a center of excellence for pharmacy practice in the region.

Significant Achievements:

  • Successfully received and maintained accreditation from the American Society of Health-System Pharmacists (ASHP) as the first hospital outside the USA for both PGY-1 & PGY-2 (Solid Organ Transplant) residency program.
  • Successfully received re-accreditation from the Accreditation Council for Pharmacy Education (ACPE) as pharmacy education provider as the first & the only hospital outside USA without any observation/citation.
  • Successful implementation of many state-of-the-art IV robotic preparation system (e.g. RIVA™)

 

Scope of Services:

Department of Ambulatory Care Pharmacy

Ambulatory care pharmacy department is one of the three departments under the Pharmaceutical Care Division including:

  • Main Outpatient Pharmacy
  • North Tower Pharmacy
  • Discharge Pharmacy
  • Emergency Pharmacy
  • KFSH East Pharmacies
  • Oncology Pharmacies

 

The goal of this department is to provide comprehensive, 24-hour computerized services to all ambulatory care patients throughout the hospital. The geographic location of these outpatient pharmacies are designed to serve the outpatient clinics that are scattered around the hospital for convenience of our patients. The Main Outpatient Pharmacy, which is located at the basement of Main Outpatient building, serves medication orders for majority of the main clinics as well as provide mail order services to patients throughout the Kingdom via DHL, whereas, other pharmacies provide comprehensive services based on individual needs of their patients     

Department of Medical/Critical Care Pharmacy

  • Satellite Pharmacy: Located in different areas of the hospital to enable immediate delivery of pharmaceutical care to medical and critical patient care areas. The location of the satellites was determined based on acuity level of the patients, volume and nature of medical orders generated by various areas. These satellite pharmacies provide pharmaceutical care to more than 312 beds in 19 different nursing units.

 

  • King Fahad National Center for Children’s Cancer (KFNCCC) Pharmacy: provides a full range of pharmaceutical care for all pediatric hematology/oncology patients, utilizing state-of-the-art automation technology, with highly educated and trained staff. The pharmacy resembles a miniature of the main pharmacy having a Unit Dose Pharmacy, Ambulatory Care Pharmacy, Day Treatment Pharmacy, IV Admixtures/Chemotherapy Preparation Services, Clinical and TPN Pharmacy Services.

 

  • Pharmacy Practice Residency Program (PGY-1): it is the first accredited pharmacy residency program by the ASHP outside the United States. The two years residency program is designed to provide high-quality training to residents both in general pharmacy practice areas and clinical services. For details, please refer to pharmacy practice residency.

Department of Medication Safety/Clinical Pharmacy Support Services

  • Inpatient Pharmacy: provides 24/7 state of the art pharmaceutical care to all hospital floors according ASHP and JCIA standards. This pharmacy covers most non critical units during day hours, and takes over all units after midnight hence, making it an area of great complexity.

 

  • IV Admixture Pharmacy: is the first USP-797 compliant IV admixture in the Middle East. It is responsible for compounding sterile products (CSPs) including: Total Parenteral Nutrition (TPN), chemotherapy admixture and various extemporaneous preparations, home TPN services, and intravenous antibiotics to the Home Health Care Patients to KFSH&RC patients. These services are currently provided through the effective use of ‘skill mix’ of pharmacy staff.

 

  • Total Parenteral Nutrition (TPN) Pharmacy: composed of the core team whose duties are to respond and consult for adult and pediatric TPN throughout the hospital in addition a peripheral team of pharmacist that is composed of clinical pharmacists who are responsible for TPN consults within their service. TPN pharmacist is also responsible of patient assessment, if they are deemed candidates for TPN, prescribing TPN, and followed the patient until he/she is able to be fed enterally.

 

  • Medication Safety and Quality Service: this service is involved in the continuous monitoring and improvement of the medication use process in the hospital, with the purpose of assuring safe and timely process and facilitates continuous evaluation of the medication management system to implement strategies that reflect medication safety best practices and eliminate actual and potential system failures and errors. It also ensures compliance with the related accreditation standards.

Others

  • Drug Information Center (DIC): it responds to requests from all patients and health care workers as well as from local drug authorities and other hospitals in the Kingdom and the Gulf region. Its ultimate goal is to provide accurate, adequate, evidenced-based drug information and patient–specific pharmacotherapy consultation service in a timely manner to all persons requesting such information. DIC also maintain adverse drug reaction (ADR) reporting system.

 

  • Investigational Drug Service (IDS): it provides support to all approved investigational studies involving medications in addition to planning, monitoring and dispensing non-formulary agents to KFSH&RC patients.

 

  • Pharmacy Automation and Support Service: this section is responsible for reviewing, developing, implementing and providing support to pharmacy automation and informatics systems to different areas of the pharmaceutical care division such as, Pharmacy Information Systems, Pharmacy Web Applications, Software Interfaces and Connectivity with pharmacy robotics and other automation systems (e.g. automated dispensing cabinets, retail pharmacy robotics, sterile compounding robotics, smart pumps, and point-of-care bedside medication scanning technologies).

 

  • Narcotic/Controlled Medications Pharmacy Services: it is responsible for all issues involving any narcotic/controlled medications transactions, starting from procuring, clearing, receiving, storing, and dispensing of this type of medications.

 Unique Expertise:

  • A regional leader in the Pharmacy Automation and Informatics field, with highly trained and experienced staff.
  • Specialized clinical pharmacy services in various critical areas, which is considered the largest clinical pharmacy coverage nationwide.
  • Comprehensive pharmaceutical services that yield safe and cost effective drug selection, timely delivery of drug therapy, and achieve optimal patient outcomes.
  • Medication safety initiatives that included identifying and flagging high alert medications, implementing automated dispensing system and bar-coding technology, and creating medication safety learning modules that include medication double-checking process.

New State-of-the-art Technology:

  • Automated Dispensing Cabinet (Pyxis MedStation® 3500 System/Pyxis ES)
  • Robotic Dispensing System (SP 200)
  • Prepackaging System (JVM)
  • IV Chemotherapy Robotic System (CytoCare)
  • IV Robotic System (RIVA)
  • Total parenteral nutrition preparation machine (Baxa ©)
  • IV Robotic System (IV Station™)
  • Narcotic Inventory System (CII Safe™)
  • Omnicell™ operating room anesthesia stations
  • Safety labeling system (Codonics ©)
  • MedBoard© medication tracking system
  • Bar Code Medication Administration (BCMA) system
  • Pharmacy supply chain management solution (PhActs)
  • Pharmacy Management System (Cerner PharmNet)
    • Online refill eService

New Services:

  • New Clinical pharmacy coverage for family medicine and ambulatory care polyclinics
  • Staff Clinical pharmacy coverage under Integrated Pharmacy Practice Models are utilized by the fresh graduates (PGY-1) to areas lacking clinical pharmacy services.

Academic & Training Activities:

  • Current status of KFSH&RC Pharmacy Residents:
  • American Society for Health-system Pharmacists (ASHP) PGY-1 Residents: 10
  • Specialized residents Solid Organ Transplantation, Total Parenteral nutrition and Cardiology: 3 (all these programs are accredited by SCFHS)
  • Saudi Career Development Participants (SCDPs) residents: 11

 

  • Students training:
  • King Saud University: Master : 10 students , PharmD : 19
  • Princess Noura University: 5
  • Alqassim University: 173

 

  • Others training programs:
  • Trainees from other hospital: 10
  • Health Outreach hospital: 2
  • International trainees : 1
  • Diploma trainees: 23

Collaborations/ Affiliations:

  • King Saud University (KSU), Riyadh, Saudi Arabia
  • AlFaisal University, Riyadh, Saudi Arabia
  • John Fisher College, Wegmans School of Pharmacy, Rochester, NY, USA
  • University of Toledo, College of Pharmacy & Pharmaceutical Sciences, Ohio, USA
  • University of Maryland, Maryland, USA
  • Alqassim University service contract for training and teaching Pharm.D. students, Saudi Arabia
  • Northern Border University, Saudi Arabia

Research Activities:

Published:

  • Possible captopril-induced toxic epidermal necrolysis.  PubMed-NCBI. 25 Aug 2015
  • The Incidence of Cisplatin Nephrotoxicity Post Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery.  Informa Healthcare.  20 Aug 2014
  • Characterization of Celecoxib-Loaded Solid Lipid Nanoparticles Formulated with Tristearin & Softisan 100.  Tropical Journal of Pharmaceutical Research.  Feb 2015
  • Community Pharmacists' Knowledge of Isotretinoin Safety.  Saudi Med.  Jan 2014
  • Knowledge and attitude of healthcare professionals toward medication pregnancy category systems in Saudi hospitals.  Saudi Med. 4 May 2014
  • Ability of Saud Mothers to appropriately and accurately use dosing devices to administer oral liquid medications to their children.  Drug Healthcare and Patient Safety.  22 Dec 2014
  • Simplicity, safety and acceptability of insulin pen use versus the conventional vial/syringe device in patients with Type 1 and 2 diabetes mellitus in Lebanon.  Patient Reference and Adherence.  27 Mar 2015
  • Introduction of vincristine mini-bags and an assessment of the subsequent risk of extravasation. J Oncol Pharm Pract. 2015 Oct;21(5):339-47
  • Determination and Characterization of metronidazole-kaolin interaction.  Saudi Pharmaceutical Journal – King Saud University.  6 Jun 2014
  • Simplicity, safety and acceptability of insulin pen use versus the conventional vial/syringe device in patients with type 1 and type 2 diabetes mellitus in Lebanon.  Patient Prefer Adherence.2015 Mar 27; 9:517-28.
  • Determination and characterization of metronidazole-kaolin interaction.  Saudi Pharm J.2015 Apr;23(2):167-76
  • A three-year study of a first-generation chemotherapy-compounding robot.  Am J Health Syst Pharm. 2015 Jun 15;72(12):1036-45

Certificates, Awards, & Accreditations:

  • ASHP accreditation on Pharmacy Practice Residency (PGY-1)— since May 2009
  • ASHP accreditation on Specialty Residency (Solid Organ Transplantation)— since April 2015
  • ACPE re-accreditation— since January 2011

 

Contact Information:

Phone: +966 011 4647272

Pharmaceutical Care Division

King Faisal Specialist Hospital & Research Center

P.O. Box 3354, Riyadh 11211 (MBC-11)

Kingdom of Saudi Arabia